Traditionally in Spain it has not been easy, compared to other countries, to create a start-up company, even less to create a technology-based start-up company (EBT).

Unfortunately, the current legal frameworks, such as the Law on Science, Technology, and Innovation (14/2011, hereinafter the "Science Law") or the Law on Incompatibilities (53/1984) do not offer many facilities to those entrepreneurs who want to take the plunge and start a new start-up.

Let us remember that, to give an example of this lack of facilities in our legal framework, the Incompatibilities Law establishes in its articles 12.1.b, 12.1.d and 16 that personnel belonging to public institutions cannot develop private activities, belong to boards of directors, hold positions in companies and participate in the capital of the company with a percentage of more than 10%.

The drafts of the new Science Law and the new Startups Law, after having analysed them, do indeed offer improvements over the current legal framework, but there is still a long way to go to improve and offer real advantages to technology-based entrepreneurs. In this opinion article we will analyze the most important aspects of each of the drafts and put them in context, looking at those that can still be improved.

NEW DRAFT OF THE SCIENCE LAW

In this draft, the first substantial change that we detected is the revision of Article 18 of the current Law. We note that it will no longer be necessary for the institution that originates the technology to necessarily become a shareholder of the new TBE (technology-based company) in order to lift the incompatibilities of those researchers who are subject to them. Let us remember that this aspect was essential in the current legal framework, and in some cases, it was a clear inconvenience or problem for those institutions that, due to their technology transfer policy, do not usually take shares in the TBEs they generate.

This aspect is relieved by the possibility of lifting incompatibilities directly through the technology license agreement. Indeed, in order to simplify the technology transfer process, the technology license agreement itself, signed between the Institution or Institutions that generate the technology and the TBE, will be sufficient to directly lift the incompatibilities of the researchers. This can be achieved by including economic rights of return to the Institutions in the license agreements. This economic right can, for example, be materialized in a plan similar to a phantom share for the institution.

If we look more closely at this aspect of incompatibilities, we also see that the other major condition currently necessary to lift the incompatibilities of the researchers, the contractual link between the TBE and the researchers, is not eliminated. It still appears that it will be necessary a part-time contract to be established between the TBE and the researchers involved. This, which is not usually a major drawback, is a barrier in itself that could be removed from the current draft.

On the other hand, what is well achieved is that the incompatibilities that made it difficult for researchers to be the Sole Administrators of the EBT have been explicitly lifted. The ambiguity in the interpretation of this issue has finally been eliminated.

Another major matter that seems to be simplified and, in a way, improved, is the management of leaves for those research personnel who request it in order to have a number of years to devote to the EBT, without jeopardizing an eventual return to their original position. In this sense, it is extended by 5 more years to the 5 years already contemplated in the current legal framework.

Finally, and outside the framework of the EBTs, we comment on an issue that has caused a great stir in the research community, and which we have no doubt will continue to do so: hiring models. The draft of the new legal framework proposes a model based on the "tenure-track" already implemented in other Anglo-Saxon countries, whereby after 5 years of a temporary contract, the objectives that the researcher undertakes to meet will be reviewed, and if they are indeed met, the contract will automatically become indefinite. This model, which may apparently offer employment stability to researchers, does not resolve key aspects such as who sets and decides these objectives or whether there is any type of regulation or rule that may define them, among other aspects that generate controversy.

Therefore, after this analysis, we can conclude that, although the incompatibility regime can be considered simplified, there are other aspects that still deserve a further revision cycle in the current draft, and that deserve to be improved, in order to have a new optimal legal framework for the research community that also wishes to create a TBE.

  • By GENESIS Biomed
  • 02/12/2021
  • Science Law, Start-ups Law, technology
  • Fuente: GENESIS Biomed

    Subscribe to Directory
    Write an Article

    Recent News

    Exposure to Heat and Cold During Pregnan...

    The research team observed changes in head circumf...

    Using mobile RNAs to improve Nitrogen a...

    AtCDF3 gene induced greater production of sugars a...

    El diagnóstico genético neonatal mejor...

    Un estudio con datos de los últimos 35 años, ind...

    Highlight

    Eosinófilos. ¿Qué significa tener val...

    by Labo'Life

    ​En nuestro post hablamos sobre este interesante tipo de célula del...

    Un estudio preclínico mejora el tratami...

    by CIMA - Centro de Investigación Médica Aplicada

    Investigadores del Cima Universidad de Navarra constatan que la combin...

    Photos Stream